The FDA bestows an Orphan Drug designation to Aytu BioPharma’s (AYTU) AR101 for the treatment of vascular Ehlers-Danlos Syndrome.
Business, Services And Guides For Music Labels
Business, Services And Guides For Music Labels
The FDA bestows an Orphan Drug designation to Aytu BioPharma’s (AYTU) AR101 for the treatment of vascular Ehlers-Danlos Syndrome.